# Chartered Group

> Chartered Group is a VC fund backing Artificial Intelligence, Apps and Drones. See 10 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 10
- Last investment: Jul 2025
- Lead investor: 90%
- Last updated: Aug 2026
- Website: http://charteredgroup.com/

Chartered Group is a VC fund focused on Artificial Intelligence and Apps. The Chartered Group is an investment platform.

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $5M–$22M |
| Series B | $30M–$40M |
| Venture - Series Unknown | $2.6M–$5M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Artificial Intelligence | 3 | 30% |
| Apps | 1 | 10% |
| Drones | 1 | 10% |
| Hardware | 1 | 10% |
| Software | 1 | 10% |

20 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 4 | 40% |
| Venture - Series Unknown | 2 | 20% |
| Series B | 1 | 10% |
| Funding Round | 1 | 10% |
| Private Equity | 1 | 10% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Israel | 4 | 40% |
| United States | 1 | 10% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| XTEND | XTEND develops AI-assisted tactical Unmanned Aircraft Systems (UAS) and the XOS operating system for remote operations. Its platforms are designed for military, security, and industrial applications, enabling intuitive control and rapid deployment. XTEND's technology supports multi-platform control, exchangeable payloads, and integration withthird-party software for diverse mission needs. | $30M | Series B | Jul 15, 2025 |  |
| CogniFiber | CogniFiber designs and builds stand-alone photonic AI accelerators for IoT analytics based on proprietary photonic deep learning processors. | $5M | Venture - Series Unknown | Jul 04, 2024 |  |
| XTEND | XTEND develops AI-assisted tactical Unmanned Aircraft Systems (UAS) and the XOS operating system for remote operations. Its platforms are designed for military, security, and industrial applications, enabling intuitive control and rapid deployment. XTEND's technology supports multi-platform control, exchangeable payloads, and integration withthird-party software for diverse mission needs. | $40M | Series B | May 08, 2024 |  |
| Zsquare | Zsquare has developed the only scalable endoscopic platform capable of transmitting high resolution images in flexible, single-use endoscopes, through polymeric fibers of any shape or size. Zsquare’s imaging technology outperforms existing technologies by delivering higher quality visualizations through smaller diameters than those found inreusable endoscopy systems.Zsquare’s polymeric fiber enables the housing of inexpensive optics with no electronics in a single-use shell, and expensive components in a detachable, reusable imaging core. This platform feature allows the use of a single core with various interchangeable shells which offer differing capabilities for different indications, facilitating any type of endoscopy procedure at a lower costs per-use. | $15M | Private Equity | Mar 01, 2022 |  |
| CogniFiber | CogniFiber designs and builds stand-alone photonic AI accelerators for IoT analytics based on proprietary photonic deep learning processors. | $6M | Series A | Feb 09, 2022 |  |
| Ridge | Ridge, the world’s most distributed cloud, unlocks the full potential of cloud computing. Its massive network of points of presence closes public cloud coverage gaps and empowers businesses to deploy applications on existing infrastructure anywhere — with no latency or data residency obstacles. Ridge’s cloud-native services, including itsCNCF-certified managed Kubernetes, are simple for DevOps and cloud architects to operate. They enable them to easily deploy cloud-native applications as part of any multi-cloud or hybrid cloud architectures. With Ridge, developers enjoy public cloud agility together with the superior performance, high throughput, and data control of private servers. | $22M | Series A | Jan 25, 2022 |  |
| XTEND | XTEND develops AI-assisted tactical Unmanned Aircraft Systems (UAS) and the XOS operating system for remote operations. Its platforms are designed for military, security, and industrial applications, enabling intuitive control and rapid deployment. XTEND's technology supports multi-platform control, exchangeable payloads, and integration withthird-party software for diverse mission needs. | $20M | Series A | Nov 16, 2021 |  |
| Pepticom Ltd. | Pepticom is a privately held AI company with headquarters in Israel committed to offering AI peptide drug discovery solutions for a better and healthier world. It is the leader in the emerging peptide drugs software solutions, AI and prediction tools that allow research centers, pharma and agriculture companies to accelerate innovative moleculesdiscovery while reducing time, costs and risks. Pepticom operates in various markets; past successful discoveries include peptide molecules related to metabolic diseases and Immuno-modulators. | $2.6M | Venture - Series Unknown | Mar 09, 2021 |  |
| Zsquare | Zsquare has developed the only scalable endoscopic platform capable of transmitting high resolution images in flexible, single-use endoscopes, through polymeric fibers of any shape or size. Zsquare’s imaging technology outperforms existing technologies by delivering higher quality visualizations through smaller diameters than those found inreusable endoscopy systems.Zsquare’s polymeric fiber enables the housing of inexpensive optics with no electronics in a single-use shell, and expensive components in a detachable, reusable imaging core. This platform feature allows the use of a single core with various interchangeable shells which offer differing capabilities for different indications, facilitating any type of endoscopy procedure at a lower costs per-use. | $10M |  |  |  |
| Pepticom Ltd. | Pepticom is a privately held AI company with headquarters in Israel committed to offering AI peptide drug discovery solutions for a better and healthier world. It is the leader in the emerging peptide drugs software solutions, AI and prediction tools that allow research centers, pharma and agriculture companies to accelerate innovative moleculesdiscovery while reducing time, costs and risks. Pepticom operates in various markets; past successful discoveries include peptide molecules related to metabolic diseases and Immuno-modulators. | $5M | Series A |  |  |

10 of 10 investments shown.

## Co-investors
- [Chartered Group](https://shizune.co/investors/profile/chartered-group-8fe9) — VC Fund, 2 deals together
- [ClalTech](https://shizune.co/investors/profile/claltech) — VC Fund, 2 deals together
- [Protego Ventures](https://shizune.co/investors/profile/protego-ventures) — VC Fund, 2 deals together
- [Union Tech Ventures](https://shizune.co/investors/profile/union-tech-ventures) — VC Fund, 2 deals together
- [Aliya Capital Partners](https://shizune.co/investors/profile/aliya-capital-partners) — VC Fund, 1 deal together
- [Eastern Epic Capitals](https://shizune.co/investors/profile/eastern-epic-capitals) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SVG Ventures](https://shizune.co/investors/profile/svg-ventures) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Omnivore](https://shizune.co/investors/profile/omnivore-partners) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [F6 Ventures](https://shizune.co/investors/profile/flat6labs) — VC Fund
- [Oqal](https://shizune.co/investors/profile/oqal) — VC Fund
- [Alesta Yatırım](https://shizune.co/investors/profile/alesta-girisim) — VC Fund

## Featured in investor lists
- [Health Care Investors in Middle East](https://shizune.co/investors/health-care-investors-middle-east)
- [Health Care VC Funds in Middle East](https://shizune.co/investors/health-care-vc-funds-middle-east)
- [Health Care VC Funds in Israel](https://shizune.co/investors/health-care-vc-funds-israel)
- [Medical Device Investors in Middle East](https://shizune.co/investors/medical-device-investors-middle-east)
- [Medical Device VC Funds in Middle East](https://shizune.co/investors/medical-device-vc-funds-middle-east)
- [Medical Device Investors in Israel](https://shizune.co/investors/medical-device-investors-israel)

## FAQ

### What does Chartered Group invest in?

Chartered Group invests primarily in Artificial Intelligence, Apps and Drones startups, most often at Series A and Venture - Series Unknown stage. Most of the 10 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Chartered Group's check size?

Chartered Group typically joins rounds of $5M–$22M at Series A, $30M–$40M at Series B and $2.6M–$5M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Chartered Group participates in.

### When did Chartered Group last invest?

The most recent investment recorded for Chartered Group closed in Jul 2025. Shizune tracks 10 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co